Weekend Unlimited (CSE:YOLO) (FWB: 0OS1) (“Weekend” or the “Company”) is pleased to announce the details of its acquisition of Northern Lights Organics in Fort St. James, British Columbia.

“Northern Lights Organics farm spans over 600 acres of organic soils to grow organic hemp for CBD and outdoor organic cannabis,” said Mr. Cody Corrubia, of Weekend Unlimited Inc. President and CEO. “Organic cannabis generally commands a 24% premium and is preferred by consumers. There are only three licensed producers currently that are organic, which puts this acquisition in a prime position to lead the industry in the hemp, CBD offerings,” added Mr. Corrubia.


As indicated in the Company’s listing statement, Weekend Unlimited has acquired 100 % of Northern Lights Organics Ltd. through a wholly owned subsidiary. This acquisition closed on or by October 10th, 2018.

Northern Lights Organics Acquisition Details:

  • Weekend Unlimited Inc., through Northern Lights Organics Ltd, a wholly owned subsidiary, has an option to approximately one section (640 acres) of organic farm lands located at Fort St. James, BC; together with a three-year option to purchase the land;
  • Weekend Unlimited Inc. paid 18 million post consolidation shares for the acquisition of Northern Lights Organics Ltd, all which are subject to a 3-year escrow release period;
  • Weekend Unlimited has agreed to issue an additional 3 million post consolidation performance shares in relation to the acquisition of Northern Lights Organics Ltd. Upon the achievement of various milestones, such as the issuance of a cultivation license and completion of a 100,000 square foot expansion greenhouse as part of a phase two expansion, Weekend will issue up to $1,700,000 worth of Weekend’s common shares, priced at the prevailing market prices, if and when, such milestones are reached.
  • Phase one construction of a 68,000 square foot greenhouse and processing building, with an approximate cost of $11,000,000, is scheduled to commence during the Spring of 2019 with a planned completion in late 2019 “the Northern Lights Organics Campus”
  • Weekend Unlimited anticipates financing the construction of the Northern Lights Organics Campus in part through a combination of equity or debt offerings
  • The lease of the farm will commence upon the attainment of certain milestones, and once in effect will be 5-years in term. During the term of the lease, Weekend anticipates exercising the option to purchase the lands. The base monthly lease payments are $4,000, subject to increases based on milestones
  • The above is an arms length transaction and no finder’s fees were involved

Northern Lights Organics Highlights:

  • With the agricultural rich land and certified organic farming expertise, Northern Lights strives to become one of Canada’s first CBD focused hemp & cannabis farm, grown from certified organic soils with final products certified organic
  • Up to 120 acres of land is anticipated to be used for outdoor organic hemp cultivation during the 2019 growing season
  • Indoor cannabis cultivation is planned to be housed in the Northern Lights Organics Campus, a 68,000 sq. ft. of purpose-built hybrid greenhouse facility with craft style grow rooms and rolling table automation
  • The Northern Lights Organics Campus will include veg, clone and genetics rooms and an extraction facility for Cannabis and CBD hemp oils and concentrates
  • As of early October, a license application has been submitted to Health Canada by Northern Lights Organics Ltd relating to the Northern Lights Organics Campus.
  • Northern Lights Organics expects to receive its cultivation license prior to the end of 2019, although there is no guarantee that the license will be obtained.

For further information, please contact:
Cody Corrubia, President & CEO
Telephone: 1 (236) 317-2812
E-mail: IR@weekendunlimited.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

Click here to connect with Weekend Unlimited (CSE:YOLO) for an Investor Presentation.

Source: www.accesswire.com

  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less